Latest Cancer vaccine Stories
Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.
Researchers at Roswell Park Cancer Institute have begun a phase I clinical research study to assess the safety and efficacy of a novel immunotherapy vaccine as treatment for melanoma.
Published in the Journal for ImmunoTherapy of Cancer, review offers recommendations for manufacturing, pre-clinical studies, and clinical trial designs of cancer immunotherapies Milwaukee,
A promising, new cancer immunotherapy combination treatment showing long term survival for patients with metastatic melanoma was highlighted today at the American Society of Clinical Oncology
- A trick or prank.